
Akero Therapeutics Inc (AKRO)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
総売上 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -25.42M | -28.75M | -35.63M | -46.62M | -61.87M | -59.95M | -65.74M | -81.7M |
税引前収入 | -23.06M | -25.83M | -31.08M | -39.66M | -55.19M | -53.34M | -55.99M | -72.71M |
純利益 | -23.06M | -25.83M | -31.08M | -39.66M | -55.19M | -53.34M | -55.99M | -72.71M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -25.42M | -25.37M | -30.23M | -38.77M | -61.87M | -59.95M | -65.74M | -81.7M |
EBITDA | -25.41M | -28.74M | -35.62M | -46.61M | -61.87M | -59.95M | -65.74M | -81.7M |
年末 2023年12月31日 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -4.56M | -13.78M | -45.65M | -80.15M | -100.89M | -115.16M | -172.87M |
税引前収入 | -4.56M | -81.71M | -43.76M | -79.21M | -100.78M | -112.03M | -151.76M |
純利益 | -4.78M | -82.23M | -43.76M | -79.21M | -100.78M | -112.03M | -151.76M |
優先配当 | -213k | -520k | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -6.864 | -111.883 | -1.532 | -2.28 | -2.89 | -2.391 | -2.724 |
EBIT | -4.56M | -81.71M | -45.65M | -80.15M | -100.89M | -115.16M | -172.87M |
EBITDA | -4.56M | -13.78M | -45.65M | -80.14M | -100.85M | -115.11M | -172.84M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約